The hypothalamic-pituitary-adrenal axis in depression

MARCELA JULIO PIEPER, Timothy G. Dinan

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

2 Scopus citations

Abstract

The hypothalamic-pituitary-adrenal (HPA) axis is the core endocrine stress system in humans. While corticotropin-releasing hormone (CRH) and vasopressin are the major secretagogue peptides of the HPA axis/stress system, glucocorticoids play a pivotal feedback role in the regulation of the HPA axis. Both the peak and the nadir in circulating cortisol concentrations are elevated in depression, but overall there is little reduction in amplitude of the circadian rhythm and neither is its timing significantly shifted. CRH has been administered following pretreatment with dexamethasone, which results in augmented adrenocorticotropic hormone and cortisol responses in depressed patients compared to normal controls. Studies have also shown that women who were sexually or physically abused in childhood exhibit a markedly enhanced activation of the HPA axis. To date, most largescale studies of compounds targeting the HPA axis have produced disappointing results. Whether or not the HPA axis is an appropriate target for novel antidepressants has yet to be convincingly demonstrated.

Original languageEnglish
Title of host publicationDepression
Subtitle of host publicationFrom Psychopathology to Pharmacotherapy
PublisherS. Karger AG
Pages20-31
Number of pages12
Volume27
ISBN (Electronic)9783805596060
ISBN (Print)9783805596053
DOIs
StatePublished - 17 Nov 2010
Externally publishedYes

Fingerprint Dive into the research topics of 'The hypothalamic-pituitary-adrenal axis in depression'. Together they form a unique fingerprint.

Cite this